Zhu et al. designed resveratrol nanoparticles to inhibit RCC cell migration and invasion by regulating matrix metalloproteinase 2 (MMP-2) expression and the extracellular signal-regulated kinase (ERK) pathway [51]. Here, MMP2 is linked to renal cell carcinoma.